MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
95.24
-0.50
-0.52%
Opening 15:21 05/20 EDT
OPEN
95.11
PREV CLOSE
95.73
HIGH
95.41
LOW
93.37
VOLUME
161.76K
TURNOVER
0
52 WEEK HIGH
97.97
52 WEEK LOW
70.74
MARKET CAP
4.84B
P/E (TTM)
38.54
1D
5D
1M
3M
1Y
5Y
HAEMONETICS CORPORATION Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended March 30, 2024
Press release · 5h ago
Weekly Report: what happened at HAE last week (0513-0517)?
Weekly Report · 10h ago
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
NASDAQ · 3d ago
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
NASDAQ · 3d ago
Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 6d ago
Haemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial Optimism
TipRanks · 6d ago
Weekly Report: what happened at HAE last week (0506-0510)?
Weekly Report · 05/13 09:02
Haemonetics Is Maintained at Market Outperform by JMP Securities
Dow Jones · 05/10 17:02
More
About HAE
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.

Webull offers Haemonetics Corporation stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.